Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 15Acupuncture Therapy 15Fentanyl 14Morphine 13Acetaminophen 13Analgesia 12Lidocaine 11Ketamine 11Bupivacaine 11Methadone 10Therapeutics 9Ropivacaine 9Psychiatric Rehabilitation 9Oxycodone 9Hydromorphone 7Saline Solution 6Radiotherapy 6Music Therapy 6Early Intervention, Educational 6Zoledronic Acid 5Yoga 5Water 5Methods 5Control Groups 5Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Physical Therapy Modalities 4Massage 4Ketorolac 4Exercise 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pain × Baclofen × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡